Recombinant Human VIPR2 Protein
Beta LifeScience
SKU/CAT #: BLK-00209P-100UG
Human VIPR2 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human VIPR2 Protein
Beta LifeScience
SKU/CAT #: BLK-00209P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
| Description | Recombinant Human VIPR2 Protein is expressed from HEK293 with mFc tag at the C-terminus.It contains Glu24-Val126. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Accession | P41587 |
| Target Symbol | VIPR2 |
| Species | Human |
| Expression System | HEK293 |
| Tag | C-mFc |
| Expression Range | Glu24-Val126 |
| Mol. Weight | The protein has a predicted MW of 37.35 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin | Less than 1EU per ug by the LAL method. |
| Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | Shipped at ambient temperature. |
| Gene Background | Effects of vasoactive intestinal peptide (VIP) on T cell migration are mediated by structurally distinct types I (VIPR1) and II (VIPR2) G protein-associated receptors. The two receptor types were proposed to transduce opposite effects on human T cells, since cytokine-induced chemotaxis of VIPR1-bearing HuT 78 human T cells, in contrast to T cells that express VIPR2, was inhibited by VIP. |
